FindTrial
Sign In

The expression and significance of reactive oxygen species modulator 1 in cancer issue of patients with human colon cancer

The expression and significance of reactive oxygen species modulator 1 in cancer issue of patients with human colon cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-12002236
Enrollment
Unknown
Registered
2012-06-03
Start date
2012-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon cancer

Interventions

the test group and the control group:nothing

Sponsors

Second Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 90 Years

Inclusion criteria

Inclusion criteria: Required surgery and preoperative colon cancer tissue pathology confirmed the results for malignant tumors

Exclusion criteria

Exclusion criteria: Required surgery but preoperative colon cancer tissue pathology results for benign tumor; Required surgery but have operation contraindication disease

Design outcomes

Primary

MeasureTime frame
reactive oxygen species modulator;—

Countries

China

Contacts

Public ContactDaihua Zhu
geoffroy324@yahoo.com.cn+86 13883175819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026